Article info
PDFOriginal article
High intensity of cytoplasmic peroxiredoxin VI expression is associated with adverse outcome in diffuse large B-cell lymphoma independently of International Prognostic Index
- Correspondence to Milla Elvi Linnea Kuusisto, Department of Oncology and Radiotherapy, University of Oulu, Medical Research Center and Oulu University Hospital, Kajaanintie 50, Oulu 90220, Finland; milla.kuusisto{at}student.oulu.fi
Citation
High intensity of cytoplasmic peroxiredoxin VI expression is associated with adverse outcome in diffuse large B-cell lymphoma independently of International Prognostic Index
Publication history
- Received November 30, 2014
- Revised March 12, 2015
- Accepted March 18, 2015
- First published May 2, 2015.
Online issue publication
June 19, 2015
Article Versions
- Previous version (2 May 2015).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions